Dutch court instructs Oculus to rectify marketing claims about Pentacam

iopticsi-Optics successfully responds to Oculus in their efforts to stop a new company promoting novel and innovative solutions to surgeons.

The Hague, September 2 2015 – i-Optics, a pioneer in the development of high quality eye diagnostic solutions, announces today in response to the press release of Oculus of August 31 2015 that the Dutch court instructed Oculus to rectify certain misleading marketing claims.

Jeroen Cammeraat, CEO of i-Optics comments “We at i-Optics prefer to focus on our customers and bringing truly innovative solutions to surgeons and patients. Our latest product Cassini featured in the 2014 Technology Award by Cataract & Refractive Surgery Today and the 2014 Innovation Award by The Ophthalmologist. Many of our customers, who are leading surgeons and highly respected scientists, have testified that Cassini enables them achieving optimal refractive outcomes in cataract surgery. We prefer to have the experts decide on which technology works best for them, rather than pursuing court cases”.

i-Optics responded to Oculus legal efforts by successfully filing claims against the German company. In their judgment the Dutch court instructed Oculus to rectify misleading marketing claims.

Jeroen Cammeraat comments “We have developed the Cassini with surgeons, for surgeons because we believe in the opportunity to achieve spectacle free cataract surgery outcomes. Since the introduction in 2013, many leading surgeons have decided to add Cassini to their cataract platform. The ability to accurately measure total corneal astigmatism, including the posterior cornea has been widely recognized as a critical link. We trust our customers’ judgment in choosing what’s right for them and look forward to further advancing the unique technology platform that Cassini offers”.

About i-Optics

i-Optics pioneers smart and high quality eye diagnosis solutions that are affordable, fast and user-friendly for care providers worldwide to serve their patients best. Its innovations include:

  • Cassini – A first-of-its-kind Corneal Shape Analyzer based on Color LED Technology. Cassini measures the axis and magnitude of corneal astigmatism with great accuracy and precision and is essential for premium IOL planning. Cassini completes the premium cataract-refractive platform.
  • EasyScan – A breakthrough, zero-dilation retinal imaging system that uses SLO technology to diagnose retinal diseases including diabetic retinopathy, age-related macular degeneration (AMD) and glaucoma.